期刊文献+

错配杂交化学发光法定量检测p16基因过甲基化 被引量:6

Chemiluminescence quantitative detection of p16 promoter hypermethylation based on mismatch hybridization
原文传递
导出
摘要 目的建立一种基于错配杂交化学发光检测p16基因启动子区过甲基化的定量分析方法.方法用亚硫酸氢钠修饰基因组DNA,所有未甲基化的胞嘧啶都被转变为尿嘧啶,而甲基化的胞嘧啶则不发生变化.设计合成1对不含CpG位点的引物,同时扩增甲基化或非甲基化目的DNA片段,用2条分别与甲基化及非甲基化CpG位点互补的寡核苷酸探针与扩增产物进行杂交及化学发光检测,通过探针杂交信号强度比确定样品DNA中甲基化的p16基因的比例.结果错配杂交化学发光法具有较好的精密度(CV=5.2%~6.4%)和灵敏度(2.5×10-4pmol),检测已知混合样品的p16基因甲基化率分别为0%、23%、52 %、70% 及93%,与实际结果一致.结论本研究建立的错配杂交化学发光法是一种检测快速、操作简便的p16基因甲基化的定量检测方法. Objectives To establish a novel method for quantitative detection of p16 promoter hypermethylation by use of mismatch hybridization and chemiluminescence. Methods Genomic DNA was modified by sodium bisulfite, so that all unmethylated cytosines were converted to uracil and a pair of primer, which had no CpG sites, was designed for amplification target DNA contained methylated or unmethylated CpG sites. Two oligonucleotide probes, which perfectly match the methylated and unmethylated CpG sequences respectively, were synthesized. The PCR products spanning CpG sites were hybridized with two oligonucleotide probes, aThe hybrids were detected by chemiluminescence. The percentage of methylated target sequences could be estimated by calculating the ratio of signals of two probes. Results The method showed an excellent precision( CV = 5.2% - 6.4% ) and detection limit (2. 5 × 10^-4 pmol). The mixtures sampls of methylated and unmethylated DNA were analysed by this method and the results were agreed with the target value. Conclusion Compared with the existing methods, this assay is a simple, sensitive and specific method for quantitative analysis of the promoter methylation of p16 gene.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第10期1057-1059,共3页 Chinese Journal of Laboratory Medicine
基金 国家自然科学基金资助项目(39990570)
关键词 P16基因 甲基化 错配杂交化学发光法 p16 gene Methylation Chemihuminescence quanititative detection
  • 相关文献

参考文献11

  • 1Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996,93:9821-9826.
  • 2Lo YM, Wong IH, Zhang J, et al. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res, 1999, 59: 3899-3903.
  • 3Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res, 2000,60:5954-5958.
  • 4吴晓明,周宜开,任恕,郝巧玲.错配杂交化学发光法检测细胞色素P4501A1基因多态性[J].分析化学,2002,30(11):1355-1358. 被引量:3
  • 5Gonzalez-zulueta M, Bender CM, Yang AS, et al. Methylation of the C 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res, 1995,55:4531-4535.
  • 6Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing:systematic investigation of critical experimenyal parameters. Nucleic Acids Res, 2001,29 : E65-5.
  • 7Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTSlgene is frequently associsaed with aberrant DNA methylation in all common human cancer. Cancer Res, 1995,55:4525-4530.
  • 8Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A,1998, 95:11891-11896.
  • 9Gonzalez-Zulueta M, Bender CM, Yang AS, et al. Methylation of the 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res, 1995,55:4531-4535.
  • 10Estellar M, Sanchez-Cespedes M, Rosell R, et al. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res,1999,59:67-70.

二级参考文献7

  • 1[1]Raunio H, Husgafvel-Pursiainen K, Anttila S. Gene.,1995,159(1):113~121
  • 2[2]Kawajiri K, Eguchi H, Nakachi K. Cancer Research,1996,56:72~76
  • 3[3]Chen S, Xue K, Xu L. Mutation Research,2001; 458:41~47
  • 4[4]Stucher I, Jacquet M, de Waziers. Pharmacogenetics,2000,10:617~27
  • 5[6]Song N, Tan W, Xing D Y. Carcinogenesis,2001,22:11~16
  • 6[7]Klingler K R, Junold T, Wielckens K. Clinical Chemistry,1999,45:1925~1931
  • 7[8]Ikuta S, Takagi K, Wallace R B. Nucleic Acids Research,1987,15:797~811

共引文献13

同被引文献66

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部